[{"address1": "9350 Kirby Drive", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77054", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 43, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 399251, "exercisedValue": 0, "unexercisedValue": 39127}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel", "age": 33, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Monic  Stuart M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.96, "open": 5.99, "dayLow": 5.4001, "dayHigh": 5.99, "regularMarketPreviousClose": 5.96, "regularMarketOpen": 5.99, "regularMarketDayLow": 5.4001, "regularMarketDayHigh": 5.99, "beta": 1.54, "forwardPE": -4.142857, "volume": 11125, "regularMarketVolume": 11125, "averageVolume": 21346, "averageVolume10days": 24013, "averageDailyVolume10Day": 24013, "bid": 4.21, "ask": 6.96, "bidSize": 200, "askSize": 200, "marketCap": 49144244, "fiftyTwoWeekLow": 2.4, "fiftyTwoWeekHigh": 9.6799, "priceToSalesTrailing12Months": 14.798658, "fiftyDayAverage": 4.467046, "twoHundredDayAverage": 4.101893, "currency": "USD", "enterpriseValue": 37820784, "profitMargins": -1.705, "floatShares": 6759247, "sharesOutstanding": 8919100, "sharesShort": 117209, "sharesShortPriorMonth": 59034, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.013099999, "heldPercentInsiders": 0.12204, "heldPercentInstitutions": 0.22361, "shortRatio": 3.65, "shortPercentOfFloat": 0.0182, "bookValue": 1.325, "priceToBook": 4.1584907, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -12213892, "trailingEps": -1.38, "forwardEps": -1.33, "lastSplitFactor": "1:12", "lastSplitDate": 1473984000, "enterpriseToRevenue": 11.389, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MRKR", "underlyingSymbol": "MRKR", "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "firstTradeDateEpochUtc": 884183400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f52316f7-d523-378a-bebe-a89c89d1c289", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.51, "targetHighPrice": 12.5, "targetLowPrice": 11.0, "targetMeanPrice": 11.75, "targetMedianPrice": 11.75, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 11323428, "totalCashPerShare": 1.27, "quickRatio": 5.719, "currentRatio": 6.117, "totalRevenue": 3320858, "revenuePerShare": 0.375, "returnOnAssets": -0.38127998, "returnOnEquity": -0.88181996, "freeCashflow": -7939947, "operatingCashflow": -14388784, "revenueGrowth": 0.008, "grossMargins": -1.89543, "operatingMargins": -2.04895, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-19"}]